The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

Germany's Merck KGaA is poised to increase the size of its life sciences business, which provides tools for research, drug discovery, and manufacturing, with an $11.3 billion deal to acquire US rival ...

June 25 (Reuters) - German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne Corp for $11.3 ...

Learn more Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) ...

The transaction is a big splash for Merck KGaA, representing the company’s largest deal since its buyout of Sigma-Aldrich for ...

Merck broadens life sciences reach. Acquisition strengthens research capabilities. Biotech expansion supports long-term ...

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

Merck KGaA's agreement to buy Bio-Techne for $11.3 billion strengthens its hold in life sciences, especially drug discovery and gene therapy.

Merck KGaA Darmstadt, Germany worked with its trusted Sullivan & Cromwell team, while Bio-Techne tapped familiar faces at ...

Merck, a leading global science and technology company, today announced a strategic research-stage collaboration with Saturnus Bio, a Versant Ventures-founded biotech, aimed at establishing a ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.